Pharmaceuticals for Women's Health: Global Markets to 2023

Aug 2018| PHM203A| BCC Publishing

Report Highlights

The global market for women’s health therapeutics reached nearly $30.5 billion in 2018 and should reach nearly $37.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.2% for the period of 2018-2023. 

Report Includes

  • 26 data tables and 34 additional tables
  • Detailed overview of the global markets for pharmaceuticals for women's health
  • Country specific data and analysis for United States, Mexico, Germany, U.K., France, China, India, Japan, Middle East and Africa
  • A look at the regulatory environment which has been a driving force in the drug development industry
  • Information on competitor initiatives, and information with regard to demand for specialty chemicals used to develop new products and for new applications
  • A relevant patent analysis within the sector
  • Comprehensive company profiles of major Players in the Market including AbbVie Inc., Allergan PLC, Amgen Inc., Bayer Ag., Eli Lilly and Company, Johnson & Johnson Inc., Novo Nordisk and Pfizer Inc.

Report Scope

While women’s health encompasses several health issues, this report will focus on menopause-related disorders, postmenopausal osteoporosis, endometriosis, polycystic ovarian syndrome and pregnancy disorders. This report does not focus on drugs for infertility, diagnostic and drug technologies for breast cancer or therapies and diagnostics for ovarian cancer. However, we have individuals reports which discusses the scope of these health concerns in detail. The report codes for these reports are listed below: 

  • PHM194A Drugs for Infertility: Global Markets.
  • HLC143B Therapies and Diagnostics for Ovarian Cancer: Global Markets.
  • HLC209A U.S. Fertility Clinics Market.
  • HLC106B Breast Cancer Diagnostic and Drug Technologies: Global Markets.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter Name Pages Price Member Price
Full Report: Pharmaceuticals for Women's Health: Global Markets to 2023 141 $2,750 Free
Chapter- 1: Introduction5Free DownloadFree
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Technologies and Global Markets Overview10$201Free
Chapter- 4: Pipeline Assessment and Analysis10$201Free
Chapter- 5: Regulatory Structure7$141Free
Chapter- 6: Market Breakdown by Women's Health Disorders38$763Free
Chapter- 7: Market Breakdown by Region27$542Free
Chapter- 8: Competitive Landscape and Key Developments9$181Free
Chapter- 9: Company Profiles29$582Free
Chapter- 10: Appendix4$80Free
Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report